AAAAAA

   
Results: 1-9 |
Results: 9
Absence of anti-hepatitis B surface antibody after vaccination does not necessarily mean absence of immune response
Authors: Greub, G Zysset, F Genton, B Spertini, F Frei, PC
Citation: G. Greub et al., Absence of anti-hepatitis B surface antibody after vaccination does not necessarily mean absence of immune response, MED MICROBI, 189(3), 2001, pp. 165-168
Presence of low levels of anti-HBs antibody in so-called 'anti-HBc alone' subjects
Authors: Greub, G Frei, PC
Citation: G. Greub et Pc. Frei, Presence of low levels of anti-HBs antibody in so-called 'anti-HBc alone' subjects, LIVER, 21(6), 2001, pp. 380-383
Isolated antibody to hepatitis B core is associated with hepatitis C virusco-infection
Authors: Greub, G Frei, PC
Citation: G. Greub et Pc. Frei, Isolated antibody to hepatitis B core is associated with hepatitis C virusco-infection, CL MICRO IN, 6(11), 2000, pp. 629-629
Comparison of the reactogenicity and immunogenicity of a two injection combined high-dose hepatitis A and hepatitis B vaccine to those of Twinrix (TM)
Authors: Greub, G Genton, B Safary, A Thoelen, S Frei, PC
Citation: G. Greub et al., Comparison of the reactogenicity and immunogenicity of a two injection combined high-dose hepatitis A and hepatitis B vaccine to those of Twinrix (TM), VACCINE, 19(9-10), 2000, pp. 1113-1117
Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?
Authors: Mayerat, C Mantegani, A Frei, PC
Citation: C. Mayerat et al., Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection?, J VIRAL HEP, 6(4), 1999, pp. 299-304
Mutations in the basal core promoter and precore/core gene of hepatitis B virus in patients with chronic active but not acute hepatitis B
Authors: Mayerat, C Mantegani, A Spertini, F Frei, PC
Citation: C. Mayerat et al., Mutations in the basal core promoter and precore/core gene of hepatitis B virus in patients with chronic active but not acute hepatitis B, EUR J CL M, 18(12), 1999, pp. 871-878
Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay
Authors: Bayer, PM Bauerfeind, S Bienvenu, J Fabien, N Frei, PC Gilburd, B Heide, KG Hoier-Madsen, M Meroni, PL Monier, JC Monneret, G Panzeri, P Shoenfeld, Y Spertini, F Wiik, A
Citation: Pm. Bayer et al., Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay, J AUTOIMMUN, 13(1), 1999, pp. 89-93
The first combined vaccine against hepatitis A and B: an overview
Authors: Thoelen, S Van Damme, P Leentvaar-Kuypers, A Leroux-Roels, G Bruguera, M Frei, PC Bakasenas, V Safary, A
Citation: S. Thoelen et al., The first combined vaccine against hepatitis A and B: an overview, VACCINE, 17(13-14), 1999, pp. 1657-1662
Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles
Authors: Bovet, P Yersin, C Herminie, P Lavanchy, D Frei, PC
Citation: P. Bovet et al., Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles, B WHO, 77(11), 1999, pp. 923-928
Risultati: 1-9 |